Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease retinopathy, diabetic
Comorbidity C0456909|blindness
Sentences 25
PubMedID- 24563789 Tragically, this will lead to approximately 4 million people around the world losing their sight from diabetic retinopathy, the leading cause of blindness in patients aged 20 to 74 years.
PubMedID- 24525390 Several studies have documented an improvement in the quality of care for diabetes since this was introduced,1819 and the effort may have contributed to the improvement in glycaemic control documented since the late 1990s.1720 the decline in the absolute number and relative proportion of blindness certifications due to diabetic retinopathy/maculopathy among working age adults since the introduction of these public health measures may be an indicator of their effectiveness.
PubMedID- 21731317 A retrieval system for patients with avoidable blindness due to diabetic retinopathy who do not present for ophthalmic assessment in oman.
PubMedID- 23226532 Oxidative stress is a contributing factor to the development and progression of diabetic retinopathy, a leading cause of blindness in people at working age worldwide.
PubMedID- 22613266 The prevalence of diabetes in developing countries is on the increase and along with it the need to provide structured care to avoid the feared long term complications among them loss of vision and blindness due to diabetic retinopathy (dr).
PubMedID- 25961883 The following demographic and comorbidity characteristics were collected: age, gender, underlying cause of esrd, diabetic duration, height, weight, body mass index (bmi) [bmi = weight (kg) /height (m2)], presence of comorbid diseases such as hypertension, cardiovascular disease (cvd), blindness due to diabetic retinopathy, chronic pulmonary disease and malignancy.
PubMedID- 22815643 Both glaucoma and diabetic retinopathy are leading causes of irreversible blindness worldwide.19,20 diabetes mellitus is known to cause microvascular damage and may affect the autoregulatory action of the blood vessels in the retina and optic nerve.
PubMedID- 20957344 Aims/hypothesis: diabetic retinopathy, the leading cause of blindness in working-age americans, is characterised by reduced neurotrophic support and increased proinflammatory cytokines, resulting in neurotoxicity and vascular permeability.
PubMedID- 24696994 Proliferative diabetic retinopathy was the cause of blindness in 92.7% and nonproliferative diabetic retinopathy in 7.3% of cases.
PubMedID- 25974230 The major breakthrough of blindness is caused due to the diabetic retinopathy.
PubMedID- 21311662 Researchers in cape town are investigating blindness due to diabetic retinopathy.
PubMedID- 22125366 Education is a priority for the prevention of blindness due to diabetic retinopathy.
PubMedID- 24358357 Objective: diabetic retinopathy, a major cause of blindness, is characterized by increased expression of vascular endothelial growth factor (vegf), leukocyte attachment to the vessel walls and increased vascular permeability.
PubMedID- 20455344 Preventing blindness due to diabetic retinopathy.
PubMedID- 24033926 Background: blindness due to diabetic retinopathy (dr) is the major disability in diabetic patients.
PubMedID- 25907958 diabetic retinopathy, which can lead to blindness, is an end stage effect of excess cone cell death and is also associated with decreased pi3k/akt signaling [39].
PubMedID- 24288441 In addition to controlling these modifiable risk factors, regular dilated eye examinations have been shown to reduce the incidence of blindness due to diabetic retinopathy through early detection and timely treatment [42].
PubMedID- 25857227 diabetic retinopathy, a major cause of blindness, is characterized by a distinct phenotype.
PubMedID- 20238019 These vmd2-cre mice are potentially useful for dissecting cellular mechanisms of age-related macular degeneration or diabetic retinopathy, two leading causes of blindness with high relevance to gene expression in the rpe or muller cells.
PubMedID- 25999748 Diabetic macular edema (dme) is the leading cause of blindness in patients with diabetic retinopathy.1 it is characterized by vascular leakage, tissue edema, and the deposition of hard exudates in the central retina.2–4 with regard to the socioeconomic burden of the disease, dme can lead to visual impairment (vi) with consequent reduction in quality of life,5–7 and patients with dme consume significantly more healthcare resources than diabetic patients without retinal complications.8 the pan-european prevalence assessment of diabetic macular edema with visual impairment (prevail) study reported an overall prevalence (among diabetic patients) of dme of 5.4%, with a prevalence of vi due to dme of 1.9%.9 given that the prevalence of diabetes mellitus has already reached epidemic proportions worldwide, and is projected to increase further over the next 20 years,10 it is expected that vi due to dme will continue to be a significant public health problem for the foreseeable future.
PubMedID- 25945362 The major breakthrough of blindness is caused due to the diabetic retinopathy.
PubMedID- 23393674 The aim of this chapter is to introduce diabetic retinopathy, a leading cause of blindness in people of the working age.
PubMedID- 22846399 Our finding is, however, in keeping with the low prevalence of diabetic retinopathy as a cause of blindness observed during the nigerian national blindness and visual impairment survey [23].
PubMedID- 23580849 The application of nanotechnology in medicine is undergoing rapid progress, and the recent developments in nanomedicine-based therapeutic approaches may bring significant benefits to address the leading causes of blindness associated with cataract, glaucoma, diabetic retinopathy and retinal degeneration.
PubMedID- 22371719 Individuals with total blindness, those diagnosed with diabetic retinopathy, those with any vision impairment that could not be corrected with lenses; and those exhibiting symptoms compatible with vestibular problems at the time of the exam, such as vertigo, dizziness or ringing in the ears, were excluded from the study.

Page: 1